B

BIOF

BIOF

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio0% buys
BearishBullish
BIOF Live QuoteReal-time
$0.11
+$0.01(+10.60%)1M
Day Range$0.11 – $0.11
Open$0.11
Previous Close$0.11
Volume54.5K
Key Financials & Valuation
Fundamental balance sheet & market metrics
General
Market Cap$50.00B
P/E Ratio (TTM)24.5
Forward P/E21.0
EPS (TTM)$4.12
Price to Book5.2
Dividend Yield0.65%
Beta (Volatility)1.18
IndustryEquities
52-Week RangeCurrent: $0.11 (0%)
Low: $112.50High: $187.50
Wall Street Consensus
Buy
Analyst Rating
4.1/ 5.0
Target Price
$172.50+15.0% upside

Insider Buys

0

$0

Insider Sales

2

$60K

Total Volume

$60K

2 transactions

Net Activity

$60K

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
35CONFIDENCE

Sentiment Rating

Moderate Distribution

CEO Conviction Index

No Recent Signal

Key Drivers

  • •Heavy distribution: sales represent 100% of total transaction value.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
K
1

Kneppers Chris J

Dir

0 buys2 sells

$60K total

Trading History
BIOF insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Oct 28, 2026

3 weeks ago

Kneppers Chris J

Dir

Director
Sell452.0K$0.10$47K

Oct 20, 2026

1 months ago

Kneppers Chris J

Dir

Director
Sell125.5K$0.10$13K
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
BIOF Buy Conviction0%
Industry Rank#509 of 563
Volume Contribution0.0%
Total Industry Activity$16.73B

BIOF has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%. BIOF ranks #509 in insider activity out of 563 tracked companies in its industry.

Insider Trading Summary & Commentary
Automated executive transaction analysis for BIOF

Over the last 90 days, corporate insiders at BIOF (BIOF) engaged in a total of 2 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 2 were sales. The total volume of insider trading reached $60K.

The net insider activity for BIOF shows a net selling bias of $60K. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Kneppers Chris J (Dir), who traded 452.0K shares valued at $47K on Oct 28, 2026.

Live Market News & Developments
Aggregated real-time headlines for BIOF (BIOF)
6 updates

Operations used $1.03M in nine months. Blue Biofuels (BIOF) warns about continuing operations.

Stock Titan6d ago

Blue biofuels director Chris Kneppers sells $12,551 in shares

Investing.com28d ago

Blue Biofuels, Inc. (BIOF) Stock Price, News, Quote & History

Yahoo! Finance Canada2676d ago

Blue biofuels director Chris Kneppers sells $12,551 in shares By Investing.com

Investing.com Nigeria27d ago

BIOF Stock Price and Chart — OTC:BIOF

TradingView1908d ago

BIOF: Blue Biofuels, Inc. Latest Stock Price, Analysis, News and Trading Ideas

Stocktwits5454d ago

FAQs About BIOF Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for BIOF.

Based on SEC Form 4 disclosures, the Insider Confidence Score for BIOF is currently 35/100, which reflects a moderate distribution bias. This calculation accounts for a total of 0 purchases and 2 sales by company executives over the last 90 days.

The CEO Conviction Index for BIOF is rated as "No Recent Signal". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.